Assay updates to the Neuro Exploratory panel
2947
Biomarker assays
~881 million
Protein data points generated
886
Publications listed on website
Please note that these details apply to the version of the panel with article number 95391, released on July 1, 2019. This replaces the previous version with article number 95390.
Olink® Target 96 Neuro Exploratory offers simultaneous measurement of 92 proteins using just 1 µL of plasma, serum, CSF, or other types of human sample, and includes a combination of exploratory and established markers with a focus on neurology-related diseases, and biological processes such as axon development, neurogenesis and synapse assembly.
This panel is a perfect complement to our neurological disease-focused panel, Olink® Target 96 Neurology, enabling a wider, more exploratory approach to neurological studies.
Olink continuously strives to improve our multiplex biomarker panels, both in terms of technical performance and to provide assays for interesting and relevant proteins. Two assays from the original version of the Neuro Exploratory panel were therefore replaced by two new, high quality assays for proteins of relevance to neurological research. The new assays are:
These replaced the following two assays:
As data from the Neuro Exploratory panel has accumulated, it became apparent that these two assays would fit much better in a panel with 1:10-dilution than in the Neuro Exploratory panel, which uses undiluted samples.
2947
Biomarker assays
~881 million
Protein data points generated
886
Publications listed on website